tisagenlecleucel · Medicine question

Which adult lymphomas is Kymriah (tisagenlecleucel) indicated to treat, and after how many prior lines of systemic therapy?

Name: Which adult lymphomas is Kymriah (tisagenlecleucel) indicated to treat, and after how many prior lines of systemic therapy?
Published: 2026-11-08T02:02:57.701Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Kymriah (tisagenlecleucel) is indicated for adults with relapsed or refractory diffuse large B-cell lymphoma or follicular lymphoma after two or more lines of systemic therapy.

Sources for this answer

Kymriah cells dispersion for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 15Document updated 6 March 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about tisagenlecleucel